Integrated Proteins revenue drops 54% in FY26
The nano-cap firm reported annual revenue of ₹9.94 cr, down from ₹21.49 cr in the prior year, while net profit remained nearly flat.
What's new
- Revenue fell to ₹9.94 cr from ₹21.49 cr in FY2025.
- Net profit held steady at ₹0.23 cr, compared to ₹0.25 cr last year.
- The audit report is unmodified with no new strategic updates.
Why this matters
The results show a significant contraction in top-line performance for the ₹251 cr market-cap company. With no new orders or strategic shifts, the stagnant profit despite the revenue drop suggests a lack of growth momentum.
What we're watching
- Any signs of revenue stabilization in the coming quarters.
- Volume trends for this nano-cap stock.
- Future disclosures regarding business expansion.
The full read
Integrated Proteins reported its audited results for FY2026, revealing a sharp decline in business activity. Revenue fell to ₹9.94 crore from ₹21.49 crore in the previous fiscal year.
Growth stalled.
Despite the 54% drop in top-line, the company managed to keep net profit nearly flat at ₹0.23 crore, compared to ₹0.25 crore in FY2025. The filing is routine, containing an unmodified audit opinion and standard compliance disclosures, with no new orders, strategic shifts, or unexpected items to report for a company with a market capitalization of ₹251 crore. These results offer little in the way of a new trading signal, confirming a period of contraction while the lack of forward-looking commentary leaves the outlook for the business entirely unchanged.
Questions answered
- How did the company's financial performance change year-over-year?
- Revenue dropped sharply to ₹9.94 crore from ₹21.49 crore in FY2025. Net profit remained largely unchanged at ₹0.23 crore, compared to ₹0.25 crore in the previous year.
- Were there any unexpected developments in the annual report?
- No. The filing contains standard segment disclosures and an unmodified audit opinion with no new orders or strategic developments.
- What is the current market scale of Integrated Proteins?
- The company is a nano-cap entity with a market capitalization of ₹251 crore.